Revance Therapeutics Prices 3.25M Share Offering @$36.00/Share

By: via Benzinga
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced the pricing of its underwritten public offering of 3,250,000 shares of its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.